Particle.news
Download on the App Store
4 ARTICLES
·
3d ago

U.S. Updates Cervical Screening: Self-Collected HPV Tests Endorsed, Insurer Coverage Set for 2027

A coverage mandate targets access barriers as guidance pivots to more sensitive HPV testing for people overdue for screening.

Image
Image
Self-administered HPV tests will be more widely available in the U.S. and covered by private insurance companies by the beginning of next year, while access to self-testing kits remains limited in Canada.

Overview

  • HRSA’s January 5 update recommends primary high‑risk HPV screening every five years for ages 30–65, with Pap testing every three years for ages 21–29.
  • People 30–65 at average risk may self‑collect vaginal samples either in clinics or at home when using FDA‑authorized tests.
  • The Teal Wand is currently the only FDA‑cleared device for true at‑home collection, with samples mailed to a laboratory for analysis.
  • Most private insurers must cover self‑collection kits and any needed follow‑up testing without cost sharing beginning January 1, 2027.
  • Evidence‑based patient navigation for screening and follow‑up became a covered service on January 1, 2026 to help boost participation among under‑screened groups.